Rocket Pharmaceuticals completes $180 million priority review voucher sale

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. SPY
3. IONS
4. AAPL
5. ACN
6. AZN
7. ROIV
8. HOOD
9. QCOM
10. NVDA

Go back to Rocket Pharmaceuticals completes $180 million priority review voucher sale
(NASDAQ: RCKT) Delayed: 3.74 -0.12 (3.11%)
Previous Close $3.86    52 Week High $ 
Open $3.78    52 Week Low $ 
Day High $3.78    P/E N/A 
Day Low $3.68    EPS $ 
Volume 443,986